ubiquinone q1 has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Ubiquinone Q1: interacts with iron atom to form acceptor quinone complex
ubiquinone-1 : A compound composed of the standard 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of a single isoprenoid unit.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, S | 1 |
| Muroyama, A | 1 |
| Matsushima, H | 1 |
| Yoshimura, I | 1 |
| Mitsumoto, Y | 1 |
1 other study available for ubiquinone q1 and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.
Topics: Animals; Corpus Striatum; Dopaminergic Neurons; Male; Mice; MPTP Poisoning; Neuroprotective Agents; | 2012 |